Skip to main content
Figure 2 | Diabetology & Metabolic Syndrome

Figure 2

From: Blood glucose lowering activity of aloe based composition, UP780, in alloxan induced insulin dependent mouse diabetes model

Figure 2

Fasting blood glucose level. Insulin dependent diabetes was induced by administering a single intraperitoneal injection of alloxan monohydrate at a dose of 150 mg/kg to CD-1 mice. Mice (n = 15/group) were fasted overnight before measurements were taken for fasting blood glucose levels at pre-induction, week-0 (baseline), week-2 and week-4 after treatment. Data are expressed as mean ± SD. * P ≤ 0.05.

Back to article page